Use Cases

Discover how SciBite’s powerful solutions are supporting scientists and researchers.

Use Cases Overview

Bioassay Registration Departmental Search Drug Safety Electronic Laboratory Notebooks
Enterprise Fair Data LLMs & GenAI Knowledge Graphs Target Validation + Drug Repositioning
Gartner report

Gartner® How to Build Knowledge Graphs That Enable AI-Driven Enterprise Applications

 

Access report

Businessman Working on Laptop

Read report

Resources

Discover our whitepapers, spec sheets, and webinars for in-depth product knowledge.

Resources

Events

Join us at upcoming events and webinars to learn more about SciBite solutions.

Events

News

Stay informed with the latest SciBite updates, announcements, and industry news.

News

Ctrl Alt Tech Podcast

Where technology meets curiosity. In each episode, we chat with expert guests to explore a wide range of STEM topics.

Podcast

Sign up for the Podcast

About SciBite

Explore SciBite’s full suite of solutions to unlock the potential of your data.

Discover more about us

Why SciBite Management Team SciBite Academy Careers
Our Partners

We build powerful partnerships with world-leading organizations.

Our Partners

Clinical Data Partners Data Management Platforms ELN Partners Enterprise Search Partners Knowledge Graph Partners

Sign up for the Podcast

Contact Us

SciBite / Knowledge Hub / Resources / AI in action: impact and potential for effective drug repurposing [Elsevier Webinar]

AI in action: impact and potential for effective drug repurposing [Elsevier Webinar]
Blossoming Lavender and flying butterfly
Watch the full webinar

What if existing medicines could unlock entirely new treatments? Could drug development become faster, more cost-effective, and less risky? By leveraging AI to reveal hidden opportunities across the world’s biomedical knowledge, effective drug repurposing has the potential to deliver safe, life-changing therapies to patients—faster than ever before.

Hear from leading organizations including Every Cure, Rare Hope foundation, and Cure Sanfilippo foundation as they share cutting-edge research, innovative approaches, and practical strategies for effective drug repurposing.

Moderator:

  • Thomas Woodcock, Technical Sales Consultant, SciBite

Presenter(s): 

  • Nina Frost, President, Rare Hope
  • David Fajgenbaum, Co-founder & President, Every Cure
  • Cara O’Neill, Chief Scientific Officer, Cure Sanfilippo Foundation
Watch the full webinar
Headshot - Tom Woodcock
Thomas Woodcock
Technical Sales Manager, North America, SciBite

Tom has over 20 years of experience in biological and pharmaceutical sciences, spanning multiple continents and roles in research, consulting, and education. He is responsible for all SciBite’s technical engagements across the US business, including partners, prospects, and existing customers. By focusing on data as a valuable asset, Tom leverages both his specialist scientific domain expertise and passion for data science to help others solve data challenges and inform decision making through

LinkedIn
Share this article
Relevant resources, events and news
https://scibite.com/knowledge-hub/news/bridging-language-barriers-in-bio-curation/ thumbnail image News Bridging language barriers in bio-curation: An LLM-enhanced workflow for ontology translation into Japanese

Discover how SciBite is overcoming language barriers in bio-curation with LLM-enhanced workflows for accurate Japanese ontology translation and semantic search.

Read more

https://scibite.com/knowledge-hub/news/challenges-and-insights-from-a-human-disease-ontology-mapping-project/ thumbnail image News Challenges and insights from a human disease ontology mapping project

Ontologies and vocabularies standardize domain knowledge, exemplified by a recent SciBite and University of Maryland project for the Human Disease Ontology Knowledgebase.

Read more

https://scibite.com/knowledge-hub/news/biomedical-ontologies-unlocking-biomedical-data/ thumbnail image News How biomedical ontologies are unlocking the full potential of biomedical data

How SciBite’s Ontologies team takes public biomedical ontologies and tailors them so that they can be used for named entity recognition (NER)

Read more